FDA Orange Book
Generic for Emerphed
Emerphed contains ephedrine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Emerphed is ephedrine. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP1, AP2, AP3.
Run it in Rivvi
Map Emerphed and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Emerphed products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravenous | 25MG/5ML (5MG/ML) | Marketed (Rx) | None | 2 | AP3, AP2 |
| solution, intravenous | 50MG/10ML (5MG/ML) | Marketed (Rx) | AP1 | 3 | AP1, AP2 |
NDA 213407, held by NEXUS PHARMACEUTICALS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic ephedrine
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | 217721 | AP3 (A-rated, therapeutically equivalent) | October 11, 2024 | 25MG/5ML (5MG/ML) |
| GLAND PHARMA LTD | 218211 | AP1 (A-rated, therapeutically equivalent) | January 16, 2025 | 50MG/10ML (5MG/ML) |
| FRESENIUS KABI USA LLC | 218271 | AP2 (A-rated, therapeutically equivalent) | March 11, 2025 | 25MG/5ML (5MG/ML), 50MG/10ML (5MG/ML) |
| FRESENIUS KABI USA LLC | 219991 | AP2 (A-rated, therapeutically equivalent) | March 19, 2026 | 50MG/10ML (5MG/ML) |
Emerphed patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 11571398 | May 16, 2040 | Method of use | U-3183 | 213407 |
| 11464752 | May 16, 2040 | Drug product | None | 213407 |
| 11478436 | May 16, 2040 | Method of use | U-3183 | 213407 |
| 11090278 | May 16, 2040 | Method of use | U-3183 | 213407 |
| 11241400 | May 16, 2040 | Method of use | U-3183 | 213407 |
Emerphed NDC codes
Questions
Is there a generic for Emerphed?
Yes. The generic name for Emerphed is ephedrine. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP1, AP2, AP3.
What is the generic name for Emerphed?
The active ingredient in Emerphed is ephedrine, per the FDA Orange Book.
When does the Emerphed patent expire?
The last patent listed for Emerphed in the Orange Book expires May 16, 2040. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Emerphed and Ephedrine
- Generic for AkovazFDA Orange Book
- Generic for CorphedraFDA Orange Book
- Norepinephrine Releasing Agents listFDA drug class
- Alpha-Adrenergic Agonists listFDA drug class
- Beta-Adrenergic Agonists listFDA drug class
- NDC 14789-250Emerphed NDC record
- NDC 14789-251Emerphed NDC record
- NDC 14789-252Emerphed NDC record